Vulvodynia: New concepts and review of the literature

Dermatologic Clinics

Volumn 28, Issue 4, 2010, Pages 681-696

  Groysman, Vlada ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Genital tract; Multifactorial disorder; Vulvar discomfort; Vulvodynia

Indexed keywords

ALPHA INTERFERON; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BOTULINUM TOXIN A; BUPIVACAINE; CAPSAICIN; DESIPRAMINE; DULOXETINE; GABAPENTIN; INTERLEUKIN 1BETA; LAMOTRIGINE; LIDOCAINE; METHYLPREDNISOLONE; PREGABALIN; TRIAMCINOLONE ACETONIDE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGRANULOCYTOSIS; ANXIETY; ATAXIA; BLEEDING; BLURRED VISION; BURNING SENSATION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; CONFUSION; CONSERVATIVE TREATMENT; CONSTIPATION; DIET THERAPY; DISEASE CLASSIFICATION; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DRY EYE; ELECTROANALGESIA; FATIGUE; FECES INCONTINENCE; FEVER; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GYNECOLOGIC SURGERY; GYNECOLOGICAL EXAMINATION; HORMONE ACTION; HUMAN; INCREASED APPETITE; INFARCTION; INFECTION; INJECTION SITE PAIN; INTERMETHOD COMPARISON; LEUKOPENIA; LOW LEVEL LASER THERAPY; MALAISE; MYALGIA; NEUROPATHIC PAIN; PARALYSIS; PATIENT ASSESSMENT; PATIENT COUNSELING; PATIENT EDUCATION; PELVIC ORGAN PROLAPSE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; PSYCHOPHYSIOLOGY; REVIEW; SEIZURE; SIDE EFFECT; TACHYCARDIA; THROMBOCYTOPENIA; TREATMENT RESPONSE; TREMOR; UNSPECIFIED SIDE EFFECT; URINE INCONTINENCE; URINE RETENTION; VAGINITIS; VULVAR VESTIBULITIS; VULVODYNIA; WEIGHT GAIN; XEROSTOMIA;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BIOFEEDBACK, PSYCHOLOGY; BOTULINUM TOXINS; EXERCISE; FEMALE; FOOD HABITS; HUMANS; INTERFERON-ALPHA; LASER THERAPY; PAIN; PELVIC FLOOR; PHYSICAL THERAPY MODALITIES; QUALITY OF LIFE; STEROIDS; VULVAR VESTIBULITIS; VULVODYNIA;

EID: 77957119599     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2010.07.002     Document Type: Review

References (151)

1. Moyal-Barracco M., Lynch P.J. 2003 ISSVD terminology and classification of vulvodynia. A historical perspective. J Reprod Med 2004, 49:772-777.
2. Edwards L. New concepts in vulvodynia. Am J Obstet Gynecol 2003, 189(3):S24-S30.
3. Petersen C., Lundvall L., Kristensen E., et al. Vulvodynia. Definition, diagnosis and treatment. Acta Obstet Gynecol Scand 2008, 87(9):893-901.
4. McKay M. Vulvodynia: diagnostic patterns [abstract]. Dermatol Clin 1992, 10:423-433.
5. Turner M.L., Marinoff S.C. Association of human papillomavirus with vulvodynia and the vulvar vestibulitis syndrome [abstract]. J Reprod Med 1988, 33:533-537.
6. Byrne M.A., Walker M.M., Leonard J., et al. Recognizing covert disease in women with chronic vulval symptoms attending an STD clinic: value of detailed examination including colposcopy [abstract]. Genitourin Med 1989, 65:46-49.
7. Harlow B.L., Stewart E.G. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia [abstract]?. J Am Med Womens Assoc 2003, 58:82-88.
8. Bachmann G.A., Rosen R., Pinn V.W., et al. Vulvodynia: a state of-the-art consensus on definitions, diagnosis and management. J Reprod Med 2006, 51:447-456.
9. Bornstein J., Livnat G., Stolar Z., et al. Pure versus complicated vulvar vestibulitis: a randomized trial of fluconazole treatment. Gynecol Obstet Invest 2000, 50:194-197.
10. Munday P.E. Response to treatment in dysaesthetic vulvodynia. J Obstet Gynaecol 2001, 21:610-613.
11. Schmidt S., Bauer A., Greif C., et al. Vulvar pain. Psychological profiles and treatment responses. J Reprod Med 2001, 46:377-384.
12. Bergeron S., Binik Y.M., Khalife S., et al. Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria. Obstet Gynecol 2001, 98:45-51.
13. Nguyen R.H., Sanson D., Harlow B.L. Urogenital infections in relation to the occurrence of vulvodynia. J Reprod Med 2009, 54(6):385-392.
14. Marks T.A., Shroyer K.R., Markham N.E., et al. A clinical, histologic, and DNA study of vulvodynia and its association with human papillomavirus [abstract]. J Soc Gynecol Investig 1995, 2:57-63.
15. Morin C., Bouchard C., Brisson J., et al. Human papillomaviruses and vulvar vestibulitis [abstract]. Obstet Gynecol 2000, 95:683-687.
16. Shafik A. Pudendal canal syndrome as a cause of vulvodynia and its treatment by pudendal nerve decompression [abstract]. Eur J Obstet Gynecol Reprod Biol 1998, 80:215-220.
17. Cox J.T. Deconstructing vulval pain. Lancet 1995, 345:53.
18. Gaunt G., Good A., Stanhope C.R. Vestibulectomy for vulvar vestibulitis. J Reprod Med 2003, 48:591-595.
19. Traas M.A., Bekkers R.L., Dony J.M., et al. Surgical treatment for the vulvar vestibulitis syndrome. Obstet Gynecol 2006, 107:256-262.
20. Gerber S., Bongiovanni A., Ledger W., et al. Interleukin-1β gene polymorphism in women with vulvar vestibulitis syndrome. Eur J Obstet Gynecol Reprod Biol 2003, 107(1):74.
21. Pukall C.F., Binik Y.M., Khalife S., et al. Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome [abstract]. Pain 2002, 96:163-175.
22. Mascherpa F., Bogliatto F., Lynch P., et al. Vulvodynia as a possible somatization disorder: more than just an opinion. J Reprod Med 2007, 52(2):107-110.
23. Brauer M., ter Kuile M.M., Janssen S.A., et al. The effect of pain-related fear on sexual arousal in women with superficial dyspareunia. Eur J Pain 2007, 11(7):788-798.
24. Graziottin A., Castoldi E., Montorsi F., et al. Vulvodynia: the challenge of " unexplained" genital pain [abstract]. J Sex Marital Ther 2001, 27:503-512.
25. 2 laser treatment of the female genital mucosa [abstract]. Dermatology 2001, 202:371-372.
26. McKay M. Vulvodynia: a multifactorial clinical problem [abstract]. Arch Dermatol 1989, 125:256-262.
27. Edwards L., Mason M., Phillips M., et al. Childhood sexual and physical abuse: incidence in patients with vulvodynia [abstract]. J Reprod Med 1997, 42:135-139.
28. Bodden-Heidrich R., Kuppers V., Beckmann M.W., et al. Psychosomatic aspects of vulvodynia: comparison with the chronic pelvic pain syndrome [abstract]. J Reprod Med 1999, 44:411-416.
29. Granot M., Zimmer E.Z., Friedman M., et al. Association between quantitative sensory testing, treatment choice, and subsequent pain reduction in vulvar vestibulitis syndrome. J Pain 2004, 5:226-232.
30. Bohm-Starke N., Hilliges M., Falconer C., et al. Neurochemical characterization of the vestibular nerves in women with vulvar vestibulitis syndrome [abstract]. Gynecol Obstet Invest 1999, 48:270-275.
31. Chaim W., Meriwether C., Gonik B., et al. Vulvar vestibulitis subjects undergoing surgical intervention: a descriptive analysis and histopathological correlates. Eur J Obstet Gynecol Reprod Biol 1996, 68:165-168.
32. Slone S., Reynolds L., Gall S., et al. Localization of chromogranin, synaptophysin, serotonin, and CXCR2 in neuroendocrine cells of the minor vestibular glands: an immunohistochemical study [abstract]. Int J Gynecol Pathol 1999, 18:360-365.
33. Chadha S., Gianotten W.L., Drogendijk A.C., et al. Histopathologic features of vulvar vestibulitis [abstract]. Int J Gynecol Pathol 1998, 17:7-11.
34. Tympanidis P., Casula M., Yiangou Y., et al. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur J Pain 2004, 8(2):129-133.
35. Gunter J. Vulvodynia: new thoughts on a devastating condition. Obstet Gynecol Surv 2007, 62(12):812-819.
36. Woodruff J.D., Parmley T.H. Infection of the minor vestibular gland. Obstet Gynecol 1983, 62:609-612.
37. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975, 1:277-299.
38. Ashton A.K. The new sexual pharmacology: a guide for the clinicians. Principles and practice of sex therapy 2007, 509-541. Guilford Press, New York. 4th edition. S.R. Leiblum (Ed.).
39. Bohm-Starke N., Hilliges M., Blomgren B., et al. Increased blood flow and erythema in the posterior vestibular mucosa in vulvar vestibulitis. Obstet Gynecol 2001, 98(6):1067-1074.
40. Glazer H.I., Marinoff S.C., Sleight I.J. Web-enabled Glazer surface electromyographic protocol for the remote, real-time assessment and rehabilitation of pelvic floor dysfunction in vulvar vestibulitis syndrome. A case report. J Reprod Med 2002, 47:728-730.
41. Bergeron S., Brown C., Lord M.J., et al. Physical therapy for vulvar vestibulitis syndrome: a retrospective study. J Sex Marital Ther 2002, 28:183-192.
42. Bergeron S., Lord M.J. The integration of pelvi-perineal re-education and cognitive-behavioral therapy in the multidisciplinary treatment of the sexual pain disorders. Sex Marital Ther 2003, 18:135-141.
43. Meana M., Binik I., Khalife S., et al. Affect and marital adjustment in women's rating of dyspareunic pain. Can J Psychiatry 1998, 43:381-385.
44. Payne K.A., Binik Y.M., Amsel R., et al. When sex hurts, anxiety and fear orient attention towards pain. Eur J Pain 2004, 9:427-436.
45. Harlow B.L., Vitonis A.F., Stewart E.G. Influence of oral contraceptive use on the risk of adult-onset vulvodynia. J Reprod Med 2008, 53(2):102-110.
46. Bohm-Stark N., Johannesson U., Hilliges M., et al. Decreased mechanical pain threshold in the vestibular mucosa of women using contraceptives. J Reprod Med 2004, 49:888-892.
47. Straub R. The complex role of estrogens in inflammation. Endocr Rev 2007, 28(5):521-574.
48. Ting A.Y., Blacklock A.D., Smith P.G. Estrogen regulates vaginal sensory and autonomic nerve density in the rat. Biol Reprod 2004, 71(4):1397-1404.
49. Ponte M., Klemperer E., Sahay A., et al. Effects of vulvodynia on quality of life. J Am Acad Dermatol 2009, 60(1):70-76.
50. O'Hare P.M., Sherertz E.F. Vulvodynia: a dermatologist's perspective with emphasis on an irritant contact dermatitis component [abstract]. J Womens Health Gend Based Med 2000, 9:565-569.
51. Masheb R.M., Lozano C., Richman S., et al. On the reliability and validity of physician ratings for vulvodynia and the discriminant validity of its subtypes. Pain Med 2004, 5:349-358.
52. American College of Obstetricians and Gynecologists Vulvar nonneoplastic epithelial disorders. Int J Gynaecol Obstet 1998, 60:181-188.
53. Lynch P.J. Vulvodynia: a syndrome of unexplained vulvar pain, psychologic disability and sexual dysfunction. J Reprod Med 1986, 31:773-780.
54. Haefner H., Collins S., Davis G.D., et al. The vulvodynia guideline. J Low Genit Tract Dis 2005, 9:40-51.
55. Goldstein A.T., Klingman D., Christopher K., et al. Surgical treatment of vulvar vestibulitis syndrome: outcome assessment derived from a postoperative questionnaire. J Sex Med 2006, 3:923-931.
56. Landry T., Bergeron S., Dupuis M.-J., et al. The treatment of provoked vestibulodynia: a critical review. Clin J Pain 2008, 24(2):155-171.
57. Goldstein A.T., Burrows L. Vulvodynia. J Sex Med 2008, 5:5-15.
58. Goldstein A.T., Marinoff S.C., Haefner H.K. Vulvodynia: strategies for treatment. Clin Obstet Gynecol 2005, 48(4):769-785.
59. Zhu Y.Z., Yang Y.H., Zhang X.L. Zhonghua Liu Xing Bing Xue Za Zhi 1996, 17:17-19. [in Chinese].
60. Bergeron S., Binik Y.M., Khalife S., et al. The treatment of vulvar vestibulitis syndrome: towards a multimodal approach. Sex Marital Ther 1997, 12:305-311.
61. Bergeron S., Binik Y.M., Khalife S. In favor of an integrated pain-relief treatment approach for vulvar vestibulitis syndrome. J Psychosom Obstet Gynaecol 2002, 23:7-9.
62. O'Connell T.X., Nathan L.S., Satmary W.A., et al. Non-neoplastic epithelial disorders of the vulva. Am Fam Physician 2008, 77(3):321-326.
63. Edwards L., Friedrich E.G. Desquamative vaginitis: lichen planus in disguise [abstract]. Obstet Gynecol 1988, 71:832-836.
64. Edwards L. Desquamative vulvitis [abstract]. Dermatol Clin 1992, 10:325-337.
65. Bowen A.R., Vester A., Marsden L., et al. The role of vulvar skin biopsy in the evaluation of chronic vulvar pain. Am J Obstet Gynecol 2008, 199(5). 467,e1-6.
66. Danielsson I., Torstensson T., Brodda-Jansen G., et al. EMG biofeedback versus topical lidocaine gel: a randomized study for the treatment of women with vulvar vestibulitis. Acta Obstet Gynecol Scand 2006, 85:1360-1367.
67. Zolnoun D., Hartmann K., Lamvu G., et al. A conceptual model for the pathophysiology of vulvar vestibulitis syndrome. Obstet Gynecol Surv 2006, 61(6):395-401.
68. Turk D.C., Okifuji A. Psychological factors in chronic pain: evolution and revolution. J Consult Clin Psychol 2002, 70:678-690.
69. Bergeron S., Khalife S., Glazer H.I., et al. Surgical and behavioral treatments for vestibulodynia: two-and-one-half year follow-up and predictors of outcome. Obstet Gynecol 2008, 111(1):159-166.
70. Ayling K., Ussher J.M. " If sex hurts, am I still a woman?" The subjective experience of vulvodynia in hetero-sexual women. Arch Sex Behav 2008, 37:294-304.
71. Haefner H.K. Report of the International Society for the study of Vulvovaginal disease: terminology and classification of vulvodynia. J Low Genit Tract Dis 2007, 11(1):48-49.
72. Hartmann D., Strauhal M.J., Nelson C.A. Treatment of women in the United States with localized, provoked vulvodynia: practice survey of women's health physical therapists. J Reprod Med 2007, 52(1):48-52.
73. Kamdar N., Fisher L., MacNeill C. Improvement in vulvar vestibulitis with montelukast. J Reprod Med 2007, 52(10):912-916.
74. Yoon H., Chung W.S., Shim B.S. Botulinum toxin A for the management of vulvodynia. Int J Impot Res 2007, 19(1):84-87.
75. Reed B.D., Haefner H.K., Punch M.R., et al. Psychosocial and sexual functioning in women with vulvodynia and chronic pelvic pain: a comparative evaluation [abstract]. J Reprod Med 2000, 45:624-632.
76. Honig E., Mouton J.W., van der Meijden W.I. Can group B streptococci cause symptomatic vaginitis [abstract]?. Infect Dis Obstet Gynecol 1999, 7:206-209.
77. Reed B.D., Sen A., Gracely R.H. Effect of test order on sensitivity in vulvodynia. J Reprod Med 2007, 24(2). Clin J Pain, February 2008.
78. Murina F., Radici G., Bianco V. Capsaicin and the treatment of vulvar vestibulitis syndrome: a valuable alternative?. MedGenMed 2004, 6:48.
79. Zolnoun D.A., Hartmann K.E., Steege J.F. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol 2003, 102:84-87.
80. Morrison G.D., Adams S.J., Curnow J.S., et al. A preliminary study of topical ketoconazole in vulvar vestibulitis syndrome. J Dermatolog Treat 1996, 7(4):219-221.
81. Pagano R. Vulvar vestibulitis syndrome: an often unrecognized cause of dyspareunia. Aust N Z J Obstet Gynaecol 1999, 39:79-83.
82. Eva L.J., MacLean A.B., Reid W.M., et al. Estrogen receptor expression in vulvar vestibulitis syndrome. Am J Obstet Gynecol 2003, 189(2):458-461.
83. Steinberg A.C., Oyama I.A., Rejba A.E., et al. Capsaicin for the treatment of vulvar vestibulitis. Am J Obstet Gynecol 2005, 192:1549-1553.
84. Murina F., Tassan P., Roberti P., et al. Treatment of vulvar vestibulitis with submucous infiltrations of methylprednisolone and lidocaine. An alternative approach. J Reprod Med 2001, 46:713-716.
85. Walsh K.E., Berman J.R., Berman L.A., et al. Safety and efficacy of topical nitroglycerin for treatment of vulvar pain in women with vulvodynia: a pilot study. J Gend Specif Med 2002, 5(4):21-27.
86. Updike G.M., Wiesenfeld H.C. Insight into the treatment of vulvar pain: a survey of clinicians. Am J Obstet Gynecol 2005, 193(4):1404-1409.
87. McKay M. Dysesthetic (" essential" ) vulvodynia: treatment with amitriptyline [abstract]. J Reprod Med 1993, 38:9-13.
88. Reed B.D., Caron A.M., Gorenflo D.W., et al. Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors. J Low Genit Tract Dis 2006, 10(4):245-251.
89. Munday P., Buchan A., Ravenhill G., et al. A qualitative study of women with vulvodynia II. Response to a multidisciplinary approach to management. J Reprod Med 2007, 52(1):19-22.
90. Murina F., Bernorio R., Palmiotto R. The use of Amielle vaginal trainers as adjuvant in the treatment of vestibulodynia: an observational multicentric study. Medscape J Med 2008, 10:23.
91. Plante A.F., Kamm M.A. Life events in patients with vulvodynia. BJOG 2008, 115:509-514.
92. Backonja M., Beydoun A., Edwards K.R., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial [abstract]. JAMA 1998, 280:1831-1836.
93. Rose M.A., Kam P.C. Gabapentin: pharmacology and its use in pain management. Anaesthesia 2002, 57:451-462.
94. Sasaki K., Smith C.P., Chuang Y.C., et al. Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain [abstract]. Tech Urol 2001, 7:47-49.
95. Ben-David B., Friedman M. Gabapentin therapy for vulvodynia. Anesth Analg 1999, 89:1459-1460. Citation.
96. Fisher R.S., Sachdeo R.C., Pellock J., et al. Rapid initiation of gabapentin: a randomized, controlled trial. Neurology 2001, 56(6):743-748.
97. Harris G., Horowitz B., Borgida A. Evaluation of gabapentin in the treatment of generalized vulvodynia, unprovoked. J Reprod Med 2007, 52(2):103-105.
98. Dionisi B., Anglana F., Inghirami P., et al. Use of transcutaneous electrical stimulation and biofeedback for the treatment of vulvodynia (vulvar vestibular syndrome): result of 3 years of experience. Minerva Ginecol 2008, 60(6):485-491.
99. Glazer H.I. Dysesthetic vulvodynia: long-term follow-up after treatment with surface electromyography-assisted pelvic floor muscle rehabilitation [abstract]. J Reprod Med 2000, 45:798-802.
100. McKay E., Kaufman R.H., Doctor U., et al. Treating vulvar vestibulitis with electromyographic biofeedback of pelvic floor musculature [abstract]. J Reprod Med 2001, 46:337-342.
101. Hartmann E.H., Nelson C. The perceived effectiveness of physical therapy treatment on women complaining of chronic vulvar pain and diagnosed with either vulvar vestibulitis syndrome or dysesthetic vulvodynia. Journal of Women's Health 2001, 25:13-18.
102. Glazer H.I., Jantos M., Hartmann E.H., et al. Electromyographic comparisons of the pelvic floor in women with dysesthetic vulvodynia and asymptomatic women [abstract]. J Reprod Med 1998, 43:959-962.
103. Murina F., Bianco V., Radici G., et al. Transcutaneous electrical nerve stimulation to treat vestibulodynia: a randomised controlled trial. BJOG 2008, 115(9):1165-1170.
104. Cecilio S.B., Zaghi S., Cecilio L.B., et al. Exploring a novel therapeutic approach with noninvasive cortical stimulation for vulvodynia. Am J Obstet Gynecol 2008, 199(6):e6-e7.
105. Nair A.R., Klapper A., Kushnerik V., et al. Spinal cord stimulator for the treatment of a woman with vulvovaginal burning and deep pelvic pain. Obstet Gynecol 2008, 111(2 Pt 2):545-547.
106. Dykstra D.D., Presthus J. Botulinum toxin type A for the treatment of provoked vestibulodynia: an open-label, pilot study. J Reprod Med 2006, 51:467-470.
107. Sobel J.D. Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy [abstract]. Am J Obstet Gynecol 1994, 171:1215-1220.
108. Marinoff S.C., Turner M.L. Vulvar vestibulitis syndrome: an overview [abstract]. Am J Obstet Gynecol 1991, 165:1228-1233.
109. Rao A., Abbott J. Using botulinum toxin for pelvic indications in women. Aust N Z J Obstet Gynaecol 2009, 49(4):352-357.
110. Romito S., Bottanelli M., Pellegrini M., et al. Botulinum toxin for the treatment of genital pain syndromes. Gynecol Obstet Invest 2004, 58:164-167.
111. Brown C.S., Glazer H.I., Vogt V., et al. Subjective and objective outcomes of botulinum toxin type A treatment in vestibulodynia: pilot data. J Reprod Med 2006, 51:635-641.
112. Horowitz B.J. Interferon therapy for condylomatous vulvitis [abstract]. Obstet Gynecol 1989, 73:446-448.
113. Marinoff S.C., Turner M.L., Hirsch R.P., et al. Intralesional alpha interferon: cost-effective therapy for vulvar vestibulitis syndrome [abstract]. J Reprod Med 1993, 38:19-24.
114. Gerber S., Bongiovanni A.M., Ledger W.J., et al. A deficiency in interferon-alpha production in women with vulvar vestibulitis. Am J Obstet Gynecol 2002, 186:361-364.
115. Masterson B.J., Galask R.P., Ballas Z.K. Natural killer cell function in women with vestibulitis. J Reprod Med 1996, 41(8):562-568.
116. Sargeant H.A., O'Callaghan F.V. The impact of chronic vulval pain on quality of life and psychosocial well-being. Aust N Z J Obstet Gynaecol 2007, 47(3):235-239.
117. Segal D., Tifheret H., Lazer S. Submucous infiltration of betamethasone and lidocaine in the treatment of vulvar vestibulitis. Eur J Obstet Gynecol Reprod Biol 2003, 107:105-106.
118. McCormack W.M., Spence M.R. Evaluation of the surgical treatment of vulvar vestibulitis [abstract]. Eur J Obstet Gynecol Reprod Biol 1999, 86:135-138.
119. Schneider D., Yaron M., Bukovsky I., et al. Outcome of surgical treatment for superficial dyspareunia from vulvar vestibulitis [abstract]. J Reprod Med 2001, 46:227-231.
120. Bornstein J., Zarfati D., Goldik Z., et al. Vulvar vestibulitis: physical or psychosexual problem [abstract]?. Obstet Gynecol 1999, 93:876-880.
121. Solomons C.C., Melmed M.H., Heitler S.M. Calcium citrate for vulvar vestibulitis: a case report [abstract]. J Reprod Med 1991, 36:879-882.
122. Bergeron S., Bouchard C., Fortier M., et al. The surgical treatment of vulvar vestibulitis syndrome: a follow-up study. J Sex Marital Ther 1997, 23:317-325.
123. Meana M., Binik Y.M., Khalife S., et al. Biopsychosocial profile of women with dyspareunia. Obstet Gynecol 1997, 90:583-589.
124. Arnold L.D., Bachmann G.A., Rosen R., et al. Vulvodynia:characteristics and associations with comorbidities and quality of life. Obstet Gynecol 2006, 107:617-624.
125. Goetsch M.F. Simplified surgical revision of the vulvar vestibule for vulvar vestibulitis. Am J Obstet Gynecol 1996, 174:1701-1705.
126. Bornstein J., Goldik Z., Stolar Z., et al. Predicting the outcome of surgical treatment of vulvar vestibulitis. Obstet Gynecol Surv 1997, 52:618-619.
127. Kehoe S., Luesley D. Vulvar vestibulitis treated by modified vestibulectomy. Int J Gynaecol Obstet 1999, 64:147-152.
128. Lavy Y., Lev-Sagie A., Hamani Y., et al. Modified vulvar vestibulectomy: simple and effective surgery for the treatment of vulvar vestibulitis. Eur J Obstet Gynecol Reprod Biol 2005, 120:91-95.
129. Bornstein J., Abramovici H. Combination of subtotal perineoplasty and interferon for the treatment of vulvar vestibulitis. Gynecol Obstet Invest 1997, 44:53-56.
130. Reid R., Omoto K.H., Precop S.L., et al. Flashlamp-excited dye laser therapy of idiopathic vulvodynia is safe and efficacious. Am J Obstet Gynecol 1995, 172:1684-1696. [discussion: 1696-701].
131. Adanu R.M.K., Haefner H.K., Reed B.D. Vulvar pain in women attending a general medical clinic in Accra, Ghana. J Reprod Med 2005, 50(2):130-134.
132. Arnold L.D., Bachmann G.A., Rosen R., et al. Assessment of vulvodynia symptoms in a sample of US women: a prevalence survey with a nested case control study. Am J Obstet Gynecol 2007, 196(2):e1-e6.
133. Friedrich E.G. Vulvar vestibulitis syndrome. J Reprod Med 1987, 32:110-114.
134. Goetsch M.F. Vulvar vestibulitis: prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynecol 1991, 164:1609-1614.
135. Harlow B.L., Wise L.A., Stewart E.G. Prevalence and predictors of chronic lower genital tract discomfort. Am J Obstet Gynecol 2001, 185:545-550.
136. Leclair C.M., Goetsch M.F., Lee K.K., et al. KTP-Nd:YAG laser therapy for the treatment of vestibulodynia, a follow-up study. J Reprod Med 2007, 52:53-58.
137. Greenstein A., Militscher I., Chen J., et al. Hyperoxaluria in women with vulvar vestibulitis syndrome. J Reprod Med 2006, 51:500-502.
138. Baggish M.S., Sze E.H., Johnson R. Urinary oxalate excretion and its role in vulvar pain syndrome. Am J Obstet Gynecol 1997, 177:507-511.
139. Metts J.F. Vulvodynia and vulvar vestibulitis: challenges in diagnosis and management. Am Fam Physician 1999, 59:1547-1556. 1561-2.
140. Danielsson I., Sjoberg I., Ostman C. Acupuncture for the treatment of vulvar vestibulitis: a pilot study [abstract]. Acta Obstet Gynecol Scand 2001, 80:437-441.
141. Powell J., Wojnarowska F. Acupuncture for vulvodynia [abstract]. J R Soc Med 1999, 92:579-581.
142. Bachmann G.A., Rosen R., Arnold L.D., et al. Chronic vulvar and other gynaecologic pain: prevalence and characteristics in a self-reported survey. J Reprod Med 2006, 51(1):3-9.
143. Kandyba K., Binik Y.M. Hypnotherapy as a treatment for vulvar vestibulitis syndrome: a case report. J Sex Marital Ther 2003, 29:237-242.
144. Pukall C.F., Kandyba K., Amsel R., et al. Efficacy of hypnosis for the treatment of vulvar vestibulitis syndrome: a preliminary investigation. J Sex Med 2007, 4:417-425.
145. Reissing E.D., Binik Y.M., Khalife S., et al. Vaginal spasm, pain, and behavior: an empirical investigation of the diagnosis of vaginismus. Arch Sex Behav 2004, 33:5-17.
146. Davis H.J., Reissing E.D. Relationship adjustment and dyadic interaction in couples with sexual pain disorders: a critical review of the literature. Sexual and Relationship Therapy 2007, 22(2):245-254.
147. Masheb R.M., Brondolo E., Kerns R.D. A multidimensional, case-control study of women with self-identified chronic vulvar pain. Pain Med 2002, 3(3):253-259.
148. Kuile M.M., Weijenborg P.T. A cognitive-behavioral group program for women with vulvar vestibulitis syndrome (VVS): factors associated with treatment success. J Sex Marital Ther 2006, 32:199-213.
149. Fowler R.S. Vulvar vestibulitis: response to hypocontactant vulvar therapy. J Low Genit Tract Dis 2000, 4:200-203.
150. Masheb R.M., Kerns R.D., Lozano C., et al. A randomized clinical trial for women with vulvodynia: cognitive-behavioral therapy vs. supportive psychotherapy. Pain 2009, 141(1-2):31-40.
151. Bergeron S., Binik Y.M., Khalifé S., et al. A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain 2001, 91:297-306.